TIDMHCM

RNS Number : 4144H

Hutchison China Meditech Limited

12 March 2018

Press release

Publication of Form 20-F

London: Monday, March 12, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today published the Form 20-F for the financial year ended December 31, 2017. This is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/4144H_1-2018-3-12.pdf and also on the website of the Company at www.chi-med.com.

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 1). For more information, please visit: www.chi-med.com.

CONTACTS

 
Investor Enquiries 
Mark Lee, Senior Vice President, Corporate Finance 
 & Development                                       +852 2121 8200 
 
U.K. & International Media Enquiries 
Anthony Carlisle, Citigate Dewe Rogerson             +44 7973 611 888 (Mobile)   anthony.carlisle@cdrconsultancy.co.uk 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications                       +1 (917) 570 7340 (Mobile)  bmiles@bmccommunications.com 
Susan Duffy, BMC Communications                      +1 (917) 499 8887 (Mobile)  sduffy@bmccommunications.com 
 
Investor Relations 
Matt Beck, The Trout Group                           +1 (917) 415 1750 (Mobile)  mbeck@troutgroup.com 
David Dible, Citigate Dewe Rogerson                  +44 7967 566 919 (Mobile)   david.dible@citigatedewerogerson.com 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts                          +44 (20) 7886 2500

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFILVFIFLIT

(END) Dow Jones Newswires

March 12, 2018 07:22 ET (11:22 GMT)

Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Hutchison China Meditech
Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Hutchison China Meditech